SQA
ONC

Simon Quick Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Simon Quick Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-58
Closed -$10K – 729
2019
Q4 		$10K Buy
+58
New +$9.64K ﹤0.01% 404

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Simon Quick Advisors's ONC Position: Q1 2020 in Review

Simon Quick Advisors sold out of BeOne Medicines Ltd (ONC) in Q1 2020, closing a stake of 58 shares — an estimated $10K sold.

Simon Quick Advisors first reported a position in ONC in Q4 2019 and held it in 1 quarter. The position peaked at $10K in Q4 2019. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

  • Simon Quick Advisors reported no remaining BeOne Medicines Ltd position as of Q1 2020 after selling out during the quarter.
  • Simon Quick Advisors sold 58 BeOne Medicines Ltd shares in Q1 2020, an estimated $10K.
  • Simon Quick Advisors first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 1 quarter.
  • Simon Quick Advisors's BeOne Medicines Ltd position peaked at $10K in Q4 2019.
  • 215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Simon Quick Advisors's 13F filing for Q1 2020, filed 9 Apr 2020.